1. Home
  2. FTK vs PRTC Comparison

FTK vs PRTC Comparison

Compare FTK & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$14.04

Market Cap

445.8M

Sector

Industrials

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$16.79

Market Cap

386.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTK
PRTC
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
445.8M
386.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FTK
PRTC
Price
$14.04
$16.79
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
369.7K
4.7K
Earning Date
11-04-2025
08-28-2025
Dividend Yield
N/A
N/A
EPS Growth
242.12
N/A
EPS
0.93
0.20
Revenue
$220,501,000.00
$6,391,000.00
Revenue This Year
$19.47
N/A
Revenue Next Year
$11.29
N/A
P/E Ratio
$15.28
$7.87
Revenue Growth
23.56
1265.60
52 Week Low
$6.05
$13.30
52 Week High
$18.96
$23.69

Technical Indicators

Market Signals
Indicator
FTK
PRTC
Relative Strength Index (RSI) 43.11 51.25
Support Level $13.75 $16.42
Resistance Level $14.67 $16.83
Average True Range (ATR) 0.80 0.31
MACD -0.07 0.10
Stochastic Oscillator 34.00 58.99

Price Performance

Historical Comparison
FTK
PRTC

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: